Have you or your loved ones been diagnosed with stage iv bladder urothelial carcinoma ajcc v7?

You may be eligible to participate in a stage iv bladder urothelial carcinoma ajcc v7 clinical trial.

Have you or your loved ones been diagnosed with stage iv bladder urothelial carcinoma ajcc v7? You may be eligible to participate in a stage iv bladder urothelial carcinoma ajcc v7 clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Stage IV Bladder Urothelial Carcinoma AJCC v7 Clinical Trial in Chapel Hill NC
NCT02567409 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with stage iv bladder urothelial carcinoma ajcc v7?

You may be eligible to participate in a stage iv bladder urothelial carcinoma ajcc v7 clinical trial.

Have you or your loved ones been diagnosed with stage iv bladder urothelial carcinoma ajcc v7? You may be eligible to participate in a stage iv bladder urothelial carcinoma ajcc v7 clinical trial.

Active not recruiting

Male & Female

18 Years +

This study is looking to recruit 90 Participants

This phase II trial studies how well cisplatin and gemcitabine hydrochloride with or without berzosertib works in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Drugs used in chemotherapy, such as cisplatin and gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Berzosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known if cisplatin and gemcitabine hydrochloride work better alone or with berzosertib in treating patients with urothelial cancer.